Quick Answer
Krystal Biotech, Inc. reported Total Assets of $1.33 billion for fiscal year 2025.
Krystal Biotech, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.33B | +26.3% |
| 2024 | $1.06B | +29.0% |
| 2023 | $818.36M | +46.5% |
| 2022 | $558.45M | -10.8% |
| 2021 | $626.29M | +101.5% |
| 2020 | $310.84M | +48.7% |
| 2019 | $209.02M | +80.0% |
| 2018 | $116.12M | +131.7% |
| 2017 | $50.11M | +2196.7% |
| 2016 | $2.18M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.24B | +26.2% | +8.9% |
| June 30, 2025 | $1.14B | +24.1% | +6.0% |
| March 31, 2025 | $1.07B | +25.9% | +1.8% |
| December 31, 2024 | $1.06B | +29.0% | +7.5% |
| September 30, 2024 | $982.32M | +24.3% | +7.0% |
| June 30, 2024 | $917.66M | +34.2% | +7.5% |
| March 31, 2024 | $853.30M | +60.4% | +4.3% |
| December 31, 2023 | $818.36M | +46.5% | +3.5% |
- Krystal Biotech, Inc. showed an increase of +26.3% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, Krystal Biotech, Inc.’s total assets has grown by 61027.1% (from $2.18 million to $1.33 billion).
- The most recent figure is from Krystal Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: